January 30, 2012
Teva has voluntarily recalled several lots of flutamide 125 mg capsules, due to the potential presence of one imatinib mesylate 100 mg capsule. The affected lots were distributed between August 2, 2011 and January 5, 2012, and are listed below:
- Flutamide 125 mg Capsules, USP, 180 ct, NDC: 00172-4960-58
- Lot J05761, Exp. 11/2012
- Lot J15067, Exp. 1/2013
- Lot J15229, Exp. 4/2013
Stop use of the affected product(s) immediately. Complete the Stock Response Form and send to:
- Address: Inmar, Attn: Recall Coordinator, 4332 Empire Road Suite 200, Fort Worth, TX 76155.
- Email: firstname.lastname@example.org
- Fax: 1-817-868-5362
To receive the Stock Response Form, use the link below or contact Inmar at 1-800-967-5952 or www.clsnetlink.com. Upon receipt of the Stock Response Form, the company will provide a Return Good Authorization label and shipping label to return the affected product(s). For medical questions, contact Teva Medical Affairs at 1-215-641-6974. For other questions, contact Teva Customer Service at 1-800-545-8800.
Report any related adverse events to FDA’s MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch/HowToReport/DownloadForms/default.htm).
Additional information is available at the following link:
- Teva Recall Notice:
- Teva Stock Response Form:
January 30, 2012; University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.